Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure
暂无分享,去创建一个
A. Kutikhin | L. Barbarash | E. Velikanova | A. Kostyunin | R. Mukhamadiyarov | T. Glushkova | L. Bogdanov | D. Shishkova | A. Stasev | M. Rezvova | E. Ovcharenko | A. Lobov | A. Evtushenko | V. Markova | T. N. Akentyeva | B. Zainullina | Maksim A. Asanov | T. Akentyeva | M. A. Asanov
[1] A. Kutikhin,et al. Early Postoperative Immunothrombosis of Bioprosthetic Mitral Valve and Left Atrium: A Case Report , 2022, International journal of molecular sciences.
[2] Yunbing Wang,et al. A PEGylation method of fabricating bioprosthetic heart valves based on glutaraldehyde and 2-amino-4-pentenoic acid co-crosslinking with improved antithrombogenicity and cytocompatibility. , 2022, Acta biomaterialia.
[3] A. Kutikhin,et al. EMbedding and Backscattered Scanning Electron Microscopy: A Detailed Protocol for the Whole-Specimen, High-Resolution Analysis of Cardiovascular Tissues , 2021, Frontiers in Cardiovascular Medicine.
[4] E. V. Kuznetsova,et al. Cross-linking method using pentaepoxide for improving bovine and porcine bioprosthetic pericardia: A multiparametric assessment study. , 2021, Materials science & engineering. C, Materials for biological applications.
[5] A. Kutikhin,et al. Ultrastructural Pathology of Atherosclerosis, Calcific Aortic Valve Disease, and Bioprosthetic Heart Valve Degeneration: Commonalities and Differences , 2020, International journal of molecular sciences.
[6] K. Toutouzas,et al. Aortic valve: anatomy and structure and the role of vasculature in the degenerative process , 2020, Acta cardiologica.
[7] I. Zhuravleva,et al. Diepoxy- Versus Glutaraldehyde-Treated Xenografts: Outcomes of Right Ventricular Outflow Tract Reconstruction in Children , 2020, World journal for pediatric & congenital heart surgery.
[8] A. Kutikhin,et al. Development of calcific aortic valve disease: Do we know enough for new clinical trials? , 2019, Journal of molecular and cellular cardiology.
[9] G. Novo,et al. Chronic inflammation: A key role in degeneration of bicuspid aortic valve. , 2019, Journal of molecular and cellular cardiology.
[10] C. Lally,et al. Collagen fibre orientation and dispersion govern ultimate tensile strength, stiffness and the fatigue performance of bovine pericardium. , 2019, Journal of the mechanical behavior of biomedical materials.
[11] M. Ishihara,et al. Mechanisms of aortic stenosis. , 2017, Journal of cardiology.
[12] B. Prendergast,et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ , 2017, European heart journal.
[13] Mevlüt Çelik,et al. Mechanical versus bioprosthetic aortic valve replacement , 2017, European heart journal.
[14] Jeroen J. Bax,et al. Bioprosthetic Heart Valves, Thrombosis, Anticoagulation, and Imaging Surveillance. , 2017, JACC. Cardiovascular interventions.
[15] M. Sacks,et al. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties , 2017, Journal of Cardiovascular Translational Research.
[16] David Ayares,et al. Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration? , 2016, Xenotransplantation.
[17] A. Bogachev-Prokophiev,et al. Results of the Ross procedure in adults: a single-centre experience of 741 operations. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[18] O. Barbarash,et al. Prosthetic heart valve selection in women of childbearing age with acquired heart disease: a case report , 2016, Journal of Medical Case Reports.
[19] C. Otto,et al. Calcific aortic stenosis , 2016, Nature Reviews Disease Primers.
[20] Susanna Price,et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.
[21] David K. C. Cooper,et al. Xenograft bioprosthetic heart valves: Past, present and future. , 2015, International journal of surgery.
[22] O. Barbarash,et al. Impact of recipient-related factors on structural dysfunction of xenoaortic bioprosthetic heart valves , 2015, Patient preference and adherence.
[23] Jean-Paul Soulillou,et al. Potential deleterious role of anti‐Neu5Gc antibodies in xenotransplantation , 2015, Xenotransplantation.
[24] I. Alferiev,et al. The susceptibility of bioprosthetic heart valve leaflets to oxidation. , 2014, Biomaterials.
[25] U. Galili. Anti‐Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits , 2013, Immunology.
[26] P. Pibarot,et al. Improving assessment of aortic stenosis. , 2012, Journal of the American College of Cardiology.
[27] M. Sacks,et al. Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves. , 2011, Journal of biomedical materials research. Part B, Applied biomaterials.
[28] N. Vyavahare,et al. Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage. , 2009, Acta biomaterialia.
[29] Michael S Sacks,et al. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. , 2006, Biomaterials.
[30] W. Klepetko,et al. Alpha‐Gal on bioprostheses: xenograft immune response in cardiac surgery , 2005, European journal of clinical investigation.
[31] M. Sacks,et al. Response of heterograft heart valve biomaterials to moderate cyclic loading. , 2004, Journal of biomedical materials research. Part A.
[32] Dan T Simionescu,et al. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. , 2003, Journal of biomedical materials research. Part A.
[33] D. Simionescu,et al. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. , 2003, The Journal of heart valve disease.
[34] S. Sellers,et al. Platelets , 1958, JACC: Basic to Translational Science.
[35] J. M. Lee,et al. Stress state during fixation determines susceptibility to fatigue-linked biodegradation in bioprosthetic heart valve materials. , 2002, Biomedical sciences instrumentation.